{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:01:48Z","timestamp":1775149308751,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jvs.2018.04.073","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T02:09:33Z","timestamp":1555639773000},"page":"1581-1589.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling"],"prefix":"10.1016","volume":"69","author":[{"given":"Chen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2018.04.073_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A\u00a0randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.04.073_bib2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.04.073_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1540-8183.2002.tb01091.x","article-title":"Initial experience with paclitaxel-coated stents","volume":"15","author":"Grube","year":"2002","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jvs.2018.04.073_bib4","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.04.073_bib5","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1161\/01.CIR.0000130173.63105.4E","article-title":"Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes","volume":"109","author":"Lemos","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.04.073_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/bmm.11.107","article-title":"Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosis","volume":"6","author":"Karper","year":"2012","journal-title":"Biomark Med"},{"key":"10.1016\/j.jvs.2018.04.073_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","article-title":"RhoA\/Rho-kinase in the cardiovascular system","volume":"118","author":"Shimokawa","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2018.04.073_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000082873","article-title":"Stent implantation activates RhoA in human arteries: inhibitory effect of rapamycin","volume":"42","author":"Gu\u00e9rin","year":"2005","journal-title":"J\u00a0Vasc Res"},{"key":"10.1016\/j.jvs.2018.04.073_bib9","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/01.CIR.101.17.2030","article-title":"Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries","volume":"101","author":"Sawada","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.04.073_bib10","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.cellsig.2014.07.031","article-title":"CD44 acts through RhoA to regulate YAP signaling","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.jvs.2018.04.073_bib11","doi-asserted-by":"crossref","first-page":"14598","DOI":"10.1074\/jbc.M111.329268","article-title":"Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin","volume":"287","author":"Xie","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jvs.2018.04.073_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jvs.2018.04.073_bib13","doi-asserted-by":"crossref","first-page":"41589","DOI":"10.1074\/jbc.M111.250878","article-title":"Transforming growth factor-\u03b21-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor\/myocardin protein","volume":"286","author":"Wang","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jvs.2018.04.073_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/mmr.2016.5986","article-title":"A\u00a0novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model","volume":"15","author":"Huang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jvs.2018.04.073_bib15","first-page":"429","article-title":"In\u00a0vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries","volume":"80","author":"Waksman","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.04.073_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jcp.25208","article-title":"Smooth muscle cell differentiation: model systems, regulatory mechanisms, and vascular diseases","volume":"231","author":"Shi","year":"2016","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jvs.2018.04.073_bib17","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1161\/CIRCRESAHA.116.305863","article-title":"Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling","volume":"116","author":"Guo","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2018.04.073_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/cvr\/cvv176","article-title":"The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP","volume":"107","author":"McKean","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jvs.2018.04.073_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCRESAHA.107.154831","article-title":"Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle \u03b1-actin expression","volume":"101","author":"Gan","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2018.04.073_bib20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1101\/gad.1428006","article-title":"The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis","volume":"20","author":"Pipes","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.jvs.2018.04.073_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0300985809352978","article-title":"Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems","volume":"47","author":"Perkins","year":"2010","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jvs.2018.04.073_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijcard.2016.06.306","article-title":"Treading the risky ground of coronary bifurcation lesion revascularization, the \"biodegradable strategy\" may represent the lifeline","volume":"221","author":"Piraino","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvs.2018.04.073_bib23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jcin.2016.03.022","article-title":"Acute gain in minimal lumen area following implantation of everolimus-eluting ABSORB biodegradable vascular scaffolds or Xience metallic stents: intravascular ultrasound assessment from the ABSORB II trial","volume":"9","author":"Sotomi","year":"2016","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418315660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418315660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:23:39Z","timestamp":1760041419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521418315660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0741521418315660"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2018.04.073","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2018.04.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}